How does GSTK's PS Ratio compare to its peers?

GSTK is expensive based on its Price-To-Sales Ratio (43x) compared to the peer average (5.4x).

How does GSTK's PS Ratio compare vs other companies in the US Pharmaceuticals Industry?

GSTK is expensive based on its Price-To-Sales Ratio (43x) compared to the US Pharmaceuticals industry average (3x).

What is GSTK's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate GSTK's Price-To-Sales Fair Ratio for valuation analysis.

What is the Fair Price of GSTK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate GSTK's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

GSTK Stock Overview

Engages in the sowing of the seeds for cultivation and selling of cannabis. More details

GSTK fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

Rewards

Revenue grew by 1149.2% over the past year

Risk Analysis

Makes less than USD$1m in revenue ($583K)

Shares are highly illiquid

Latest financial reports are more than 6 months old

Does not have a meaningful market cap ($25M)

My Notes

Capture your thoughts, links and company narrative

Growth Stalk Holdings Corp. Competitors

Earth Science Tech

OTCPK:ETST

US$33.3m

Kiora Pharmaceuticals

NasdaqCM:KPRX

US$9.8m

CannaPharmaRX

OTCPK:CPMD

US$5.1m

Filament Health

OTCPK:FLHL.F

US$6.9m

Price History & Performance

Summary of share price highs, lows and changes for Growth Stalk Holdings
Historical stock prices
Current Share Price	US$1.09
52 Week High	US$1.10
52 Week Low	US$0.25
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	335.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	GSTK	US Pharmaceuticals	US Market
7D	0%	-0.3%	-2.7%
1Y	n/a	7.9%	23.4%

Return vs Industry: Insufficient data to determine how GSTK performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how GSTK performed against the US Market.

Price Volatility

Is GSTK's price volatile compared to industry and market?
GSTK volatility
GSTK Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.6%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.9%
10% least volatile stocks in US Market	3.2%

Stable Share Price: GSTK's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine GSTK's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2021	n/a	Joseph Babiak	www.growthstalk.com

Growth Stalk Holdings Corp. engages in the sowing of the seeds for cultivation and selling of cannabis. It also engages in the production and processing of exotic cannabis flowers, extracts and bubble hash, and live rosin from the trim of the flower. The company was incorporated in 2021 and is based in Seminole, Oklahoma.

Growth Stalk Holdings Corp. Fundamentals Summary

How do Growth Stalk Holdings's earnings and revenue compare to its market cap?
GSTK fundamental statistics
Market cap	US$25.10m
Earnings (TTM)	-US$311.16k
Revenue (TTM)	US$583.34k

43.0x

P/S Ratio

-80.7x

P/E Ratio

Is GSTK overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GSTK income statement (TTM)
Revenue	US$583.34k
Cost of Revenue	US$404.21k
Gross Profit	US$179.13k
Other Expenses	US$490.30k
Earnings	-US$311.16k

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-0.013
Gross Margin	30.71%
Net Profit Margin	-53.34%
Debt/Equity Ratio	38.2%

How did GSTK perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 11:44
End of Day Share Price	2024/10/14 00:00
Earnings	2023/12/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Growth Stalk Holdings Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution